1. IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming
   Na Niu et al, 2021, Oncogenesis CrossRef
2. TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer
   Shang-Lang Huang et al, 2021, Biochemical Pharmacology CrossRef
3. The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer
   Katarzyna D. Kania et al, 2022, Cells CrossRef
4. Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene
   Eglė Žilienė et al, 2023, Diagnostics CrossRef
5. The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers
   Luiz Antonio Lupi et al, 2020, Life Sciences CrossRef
6. Toll-Like Receptors Gene Polymorphism and Susceptibility to Cancer Development
   Abdelhabib Semlali et al, 2018, Genetic Diversity and Disease Susceptibility CrossRef
7. Toll-like receptor 4 gene polymorphism downregulates gene expression and involves in susceptibility to bladder cancer
   Yizhen Shen et al, 2015, Tumor Biology CrossRef
8. Absence of association between TLR4 Thr399Ile polymorphism and cervical cancer susceptibility
   Nilesh Pandey et al, 2018, Meta Gene CrossRef